DiappyMed
Clapiers, France
DiappyMed's goal is to lead Type 1 diabetes patients towards a more effective treatment, autonomy and empowerment by providing them with the first clinically validated mobile app for intelligent insulin dosing. Relying heavily on data science, new technologies and artificial intelligence, we aim to equip insulin-dependent patients with an all-in-one solution that will provide them with an easy-to-get and personalized insulin dose recommendation. Their first clinical trials show an improvement of patient’s blood glucose level control (time in range). The company is supported by:- Montpellier University Hospital’s Innovation Extractor- IMT Mines Alès Incubator- Montpellier BIC - University of Montpellier- Occitanie RegionWe are also in the process of building and consolidating partnerships with renowned research laboratories to work on various artificial intelligence technologies.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- diappymed.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of DiappyMed?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now